YAHAIRA MYERS: Open Payments
NPI 1831863323 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 33 payments from 11 companies in 2025. Trend: 2023 $1,413 · 2024 $539 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $165 |
| Lilly USA, LLC | 6 | $140 |
| Exact Sciences Corporation | 4 | $115 |
| ABBVIE INC. | 5 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Novo Nordisk Inc | 2 | $34 |
| Amgen Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Renalytix AI, Inc. | 1 | $19 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, Cologuard Collection Kit, MOUNJARO, VRAYLAR, XIFAXAN, ZEPBOUND, QULIPTA, EVENITY.
Industry payments across NY — which companies pay providers there.
